Wealthquest Corp Makes New Investment in GRAIL, Inc. (NASDAQ:GRAL)

Wealthquest Corp bought a new position in shares of GRAIL, Inc. (NASDAQ:GRAL) during the 1st quarter, according to its most recent 13F filing with the SEC. The firm bought 714,462 shares of the company’s stock, valued at approximately $18,247,000. GRAIL accounts for approximately 1.8% of Wealthquest Corp’s holdings, making the stock its 11th largest position. Wealthquest Corp owned approximately 2.02% of GRAIL as of its most recent filing with the SEC.

Several other hedge funds have also recently bought and sold shares of GRAL. Lindbrook Capital LLC acquired a new stake in GRAIL during the 4th quarter worth approximately $28,000. State of Tennessee Department of Treasury acquired a new stake in GRAIL during the 4th quarter worth approximately $28,000. Caldwell Sutter Capital Inc. acquired a new stake in GRAIL during the 1st quarter worth approximately $28,000. Sterling Capital Management LLC acquired a new stake in GRAIL during the 4th quarter worth approximately $29,000. Finally, Wellington Shields Capital Management LLC acquired a new stake in GRAIL during the 4th quarter worth approximately $33,000.

Insider Transactions at GRAIL

In other GRAIL news, CFO Aaron Freidin sold 41,150 shares of the firm’s stock in a transaction on Friday, May 2nd. The stock was sold at an average price of $33.93, for a total transaction of $1,396,219.50. Following the completion of the sale, the chief financial officer now owns 294,020 shares of the company’s stock, valued at $9,976,098.60. This trade represents a 12.28% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, President Joshua J. Ofman sold 48,213 shares of the firm’s stock in a transaction on Friday, May 2nd. The shares were sold at an average price of $33.93, for a total value of $1,635,867.09. Following the sale, the president now directly owns 511,460 shares of the company’s stock, valued at $17,353,837.80. This represents a 8.61% decrease in their position. The disclosure for this sale can be found here. Insiders sold 183,398 shares of company stock valued at $6,222,694 in the last ninety days.

Wall Street Analyst Weigh In

Several brokerages have commented on GRAL. Morgan Stanley raised their target price on shares of GRAIL from $16.00 to $20.00 and gave the stock an “equal weight” rating in a report on Tuesday, March 18th. Canaccord Genuity Group raised their price target on shares of GRAIL from $32.00 to $43.00 and gave the stock a “buy” rating in a research note on Wednesday, May 14th.

GRAIL Stock Up 2.0%

Shares of GRAL opened at $43.95 on Wednesday. The stock has a market capitalization of $1.58 billion and a P/E ratio of -0.72. GRAIL, Inc. has a twelve month low of $12.33 and a twelve month high of $63.99. The company has a 50 day moving average of $37.98 and a 200-day moving average of $31.32.

GRAIL (NASDAQ:GRAL) last issued its quarterly earnings results on Tuesday, May 13th. The company reported ($3.10) earnings per share for the quarter, topping the consensus estimate of ($4.03) by $0.93. The company had revenue of $31.84 million during the quarter, compared to analysts’ expectations of $35.80 million. GRAIL had a negative net margin of 1,464.53% and a negative return on equity of 17.99%. On average, sell-side analysts anticipate that GRAIL, Inc. will post -15.15 earnings per share for the current fiscal year.

About GRAIL

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.